Bristol Myers Squibb (BMY) Net Margin Growth (5y) (2014 - 2026)

Bristol Myers Squibb (BMY) Net Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 561.00
Dec 31, 2025 9,982.00
Sep 30, 2025 82.00
Jun 30, 2025 1,214.00
Mar 31, 2025 2,970.00
Dec 31, 2024 1,522.00
Sep 30, 2024 -1,125.00
Jun 30, 2024 -795.00
Mar 31, 2024 -12,766.00
Dec 31, 2023 -291.00
Sep 30, 2023 -1,403.00
Jun 30, 2023 1,358.00
Mar 31, 2023 -662.00
Dec 31, 2022 6,244.00
Sep 30, 2022 54.00
Jun 30, 2022 -353.00
Mar 31, 2022 -1,753.00
Dec 31, 2021 591.00
Sep 30, 2021 -853.00
Jun 30, 2021 -1,260.00